BioAtla, Inc.
BCAB
$1.23
-$0.03-2.38%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -31.45M | -50.62M | -59.61M | -64.71M | -59.52M |
| Total Depreciation and Amortization | 195.00K | 310.00K | 373.00K | 582.00K | 754.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.04M | 4.31M | 6.07M | 5.97M | 4.76M |
| Change in Net Operating Assets | 4.74M | 8.81M | 4.96M | 1.08M | 1.68M |
| Cash from Operations | -23.48M | -37.18M | -48.20M | -57.07M | -52.32M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 7.13M | 7.13M | 7.13M | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 469.00K | 513.00K | 100.00K | 9.36M | 9.36M |
| Repurchase of Common Stock | -33.00K | -37.00K | -52.00K | -40.00K | -48.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -742.00K | -820.00K | -897.00K | -444.00K | -444.00K |
| Cash from Financing | 6.82M | 6.78M | 6.28M | 8.88M | 8.87M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.66M | -30.40M | -41.93M | -48.20M | -43.46M |